For the year ending 2025-12-31, BBLGW has $5,796,135 in assets. $418,587 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 5,334,322 | |||
| Advances on research and development contract services | 208,972 | |||
| Prepaid insurance | 232,946 | |||
| Interest receivable | 9,895 | |||
| Prepaid expenses | 10,000 | |||
| Total current assets | 5,796,135 | |||
| Total assets | 5,796,135 | |||
| Accounts payable and accrued expenses | 417,884 | |||
| Warrant liability | 703 | |||
| Total current liabilities | 418,587 | |||
| Total liabilities | 418,587 | |||
| Common stock, 0.001 par value per share 100,000,000 shares authorized 1,795,260 and 492,417 shares issued and outstanding at december 31, 2025 and 2024, respectively | 1,795 | |||
| Additional paid-in capital | 93,506,122 | |||
| Accumulated deficit | -88,130,369 | |||
| Total stockholders equity | 5,377,548 | |||
| Total liabilities and stockholders equity | 5,796,135 | |||
Bone Biologics Corp (BBLGW)
Bone Biologics Corp (BBLGW)